Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyungseok Kang

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
ACS Applied Materials & Interfaces|August 19, 2017
Halide Welding for Silver Nanowire Network ElectrodeHyungseok Kang, Yeontae Kim, Siuk Cheon, et al.
Journal of Korean Medical Science|September 7, 2020
Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment InitiationDoosoo Jeon, Hyungseok Kang, Yong Soo Kwon, et al.
The European Respiratory Journal|October 23, 2020
Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South KoreaYong-Soo Kwon, Doosoo Jeon, Hyungseok Kang, et al.
Respiratory Medicine|May 19, 2020
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South KoreaHyungseok Kang, Kyung-Wook Jo, Doosoo Jeon, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 5, 2008
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosisSeung-Kyu Park, Jin-Hee Kim, Hyungseok Kang, et al.
Nanoscale|March 26, 2015
Positively-charged reduced graphene oxide as an adhesion promoter for preparing a highly-stable silver nanowire filmQijun Sun, Seong Jun Lee, Hyungseok Kang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2021
Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or DelamanidHyeontaek Hwang, Hyungseok Kang, Yong-Soo Kwon, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 9, 2020
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanidHoon Hee Lee, Kyung-Wook Jo, Jae-Joon Yim, et al.
The European Respiratory Journal|June 16, 2022
Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney/liver diseaseChiwook Chung, Jung Eun Shin, Doosoo Jeon, et al.
Jac-Antimicrobial Resistance|May 16, 2023
A comparison of phenotypic and WGS drug susceptibility testing in <i>Mycobacterium tuberculosis</i> isolates from the Republic of KoreaSeung Heon Lee, Elena Ferran, Adam A Witney, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
ACS Applied Materials & Interfaces|August 19, 2017
Halide Welding for Silver Nanowire Network ElectrodeHyungseok Kang, Yeontae Kim, Siuk Cheon, et al.
Journal of Korean Medical Science|September 7, 2020
Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment InitiationDoosoo Jeon, Hyungseok Kang, Yong Soo Kwon, et al.
The European Respiratory Journal|October 23, 2020
Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South KoreaYong-Soo Kwon, Doosoo Jeon, Hyungseok Kang, et al.
Respiratory Medicine|May 19, 2020
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South KoreaHyungseok Kang, Kyung-Wook Jo, Doosoo Jeon, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 5, 2008
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosisSeung-Kyu Park, Jin-Hee Kim, Hyungseok Kang, et al.
Nanoscale|March 26, 2015
Positively-charged reduced graphene oxide as an adhesion promoter for preparing a highly-stable silver nanowire filmQijun Sun, Seong Jun Lee, Hyungseok Kang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2021
Outcomes of Multidrug-Resistant Tuberculosis Treated With Bedaquiline or DelamanidHyeontaek Hwang, Hyungseok Kang, Yong-Soo Kwon, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 9, 2020
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanidHoon Hee Lee, Kyung-Wook Jo, Jae-Joon Yim, et al.
The European Respiratory Journal|June 16, 2022
Treatment outcomes of multidrug-resistant tuberculosis with chronic kidney/liver diseaseChiwook Chung, Jung Eun Shin, Doosoo Jeon, et al.
Jac-Antimicrobial Resistance|May 16, 2023
A comparison of phenotypic and WGS drug susceptibility testing in <i>Mycobacterium tuberculosis</i> isolates from the Republic of KoreaSeung Heon Lee, Elena Ferran, Adam A Witney, et al.
Pageof 2